Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 2, 26 | Daniels Ryan M. | officer: SVP, Wood Products | S-Sale | 14 @ $18.22 | $255 |
FY2025 · 10-K disclosure
Daily · Wilder smoothing
| Sep 30, 26 |
| Daniels Ryan M. |
| officer: SVP, Wood Products |
| S-Sale |
| 887 @ $18.56 |
| $16.46K |
| Sep 10, 26 | Bridwell Mark R | officer: EVP, GC and Secretary | S-Sale | 5,318 @ $20.19 | $107.4K |
| Aug 28, 26 | Bass Keith E | director | A-Award | 1,136 @ $20.38 | $23.15K |
| May 29, 26 | Bass Keith E | director | A-Award | 1,047 @ $20.89 | $21.87K |
| May 15, 26 | Bass Keith E | director | A-Award | 6,811 @ $19.82 | $135.0K |
| May 15, 26 | Covey Michael J | director | A-Award | 6,811 @ $19.82 | $135.0K |
| May 15, 26 | Jones Scott R. | director | A-Award | 6,811 @ $19.82 | $135.0K |
FY2025 · 10-K disclosure
Classic floor pivots from 2026-10-27
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 53.55 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 78.06 | Oscillator | Neutral |
| Williams %R (14) | -6.83 | Oscillator | Sell |
| MACD (12, 26, 9) | -0.18 (Hist 0.12) | Oscillator | Buy |
| Average Directional Index (14) | 29.16 (+DI 19.4 / -DI 22.0) | Trend | Strong Sell |
| EMA 20 | 18.89 | MA | Buy |
| SMA 20 | 18.61 | MA | Strong Buy |
| EMA 50 | 19.49 | MA | Sell |
| SMA 50 | 19.62 | MA | Sell |
| SMA 200 | 21.02 | MA | Strong Sell |
Stock news · updated daily
Casino landlords, timberland owners, and farm operators all collect rent in wildly different ways, and only one of these four specialty REITs has a dividend that its own earnings guidance can actually cover.
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) announced today that the Company's board of directors has declared a fourth quarter cash dividend of $0.26 per common share. The dividend is payable on December 31, 2026, to shareholders of record on December 17, 2026. The Company also announced today that the Company's board of directors, in its capacity as the board of directors of the general partner of Rayonier, L.P., has declared a fourth quarter cash distribution of $0.26 per oper.
Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) plans to release its third quarter 2026 earnings after the market closes on Wednesday, November 4, 2026.Rayonier will host a conference call and live audio webcast at 10:00 a.m. (ET) on Thursday, November 5 to discuss these results. Supplemental materials and access to the live audio webcast will be available at www.rayonier.com. A replay of the webcast will be archived on the Company's website and available shortly after the call.The co.
Packaging company Clearwater Paper was a contributor in the quarter. Alaskan cable company Liberty Capital was a contributor in the quarter. Empire State Realty's underperformance this quarter was mostly driven by its Empire State Building Observatory hitting a rough patch over the last two years. Broadband operator Shenandoah Telecommunications was a contributor for us in the first half of the year but detracted in the third quarter.
Rayonier is rated Buy with a $23.04 target, driven by asset value and a 5.5% dividend yield, over an 18–24 month horizon. My thesis emphasizes monetization of land, merger integration, and prudent NAV adjustments, rather than relying on a lumber sector rebound. Merger integration is key; $40 million in annual synergies are a goal, not a realized benefit, with cost reduction and cash conversion as priorities.
The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.
On October 08, 2026, Rayonier Inc (RYN) shares rose 3.4% today, closing at $18.60. This price is within the 52-week range of $17.71 to $26.75, reflecting signif
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | 0.10 | 0.10 | Beat 0.7% | $396.5M |
| May 6, 2026 | 0.06 | 0.07 | Beat 16.7% | $276.8M |
| Feb 11, 2026 | 0.12 | 0.20 | Beat 66.7% | $117.5M |
| Nov 5, 2025 | 0.23 | 0.32 | Beat 39.1% | $177.5M |
| Aug 6, 2025 | 0.03 | 0.06 | Beat 100.0% | $106.5M |
| Apr 30, 2025 | 0.08 | -0.02 | Miss -125.0% | $82.90M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G/A | Oct 7, 2026 | 2026-10-07 08:00:03 | View |
| 4 | Oct 6, 2026 | 2026-10-06 16:30:21 | View |
| 4 | Oct 1, 2026 | 2026-10-01 16:36:44 | View |
| 4 | Sep 11, 2026 | 2026-09-11 17:39:43 | View |
| 4 | Aug 31, 2026 | 2026-08-31 16:16:04 | View |
| 10-Q | Aug 7, 2026 | 2026-08-07 17:13:25 | View |
| 8-K | Aug 5, 2026 | 2026-08-05 16:17:50 | View |
| 8-K | Jul 17, 2026 | 2026-07-17 08:52:46 | View |
| 11-K | Jun 29, 2026 | 2026-06-29 16:13:31 | View |
| 4 | Jun 1, 2026 | 2026-06-01 16:55:50 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | RYN | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 39.2x | 34.1x · sector 36.8x | In line |
| Forward P/E (FY26E) | 45.3x | EPS est. 0.42 | Elevated |
| Price / Book | 0.6x | 2.4x | Discount |
| Price / Sales | 5.9x | 5.0x | Elevated |
| EV / EBITDA | 26.5x | 15.8x | Elevated |
| Return on equity | 2.0% | — | Weak |
| Gross margin | 17.9% | 30.1% | Below hist. |
| Debt / Equity | 0.36 | 0.72 | Conservative |
| Piotroski / Altman Z | 6/9 | Z 1.79 | Distress |
Discounted cash flow model
Current price $19.22
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 16, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Oct 12, 26 | Truist Securities | maintain | Hold | Hold |
| Oct 5, 26 | Citigroup | maintain | Neutral | Neutral |
| Aug 10, 26 | Citigroup | maintain | Neutral | Neutral |
| Jul 15, 26 | Truist Securities | maintain | Hold | Hold |
| May 19, 26 | BMO Capital | maintain | Market Perform | Market Perform |
| May 13, 26 | Citigroup | maintain | Neutral | Neutral |
| May 11, 26 | Truist Securities | maintain | Hold | Hold |
| Feb 17, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |